Results 181 to 190 of about 34,497 (254)

Antagonizing NRG1-ERBB4 signaling pathway with spironolactone for the treatment of schizophrenia: results of a randomized controlled drug repositioning clinical trial. [PDF]

open access: yesCommun Med (Lond)
Hasan A   +28 more
europepmc   +1 more source

Spironolactone or Finerenone for Cardiovascular and Kidney Protection in Patients with Moderate CKD? [PDF]

open access: yesAm J Cardiovasc Drugs
Georgianos PI   +6 more
europepmc   +1 more source

Spironolactone and clinical outcomes in patients with alcohol use disorder and comorbid hypertension: a target trial emulation study. [PDF]

open access: yesPsychopharmacology (Berl)
Loften A   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy